Similar articles

• The use of tissue thromboplastins of different origin is a fundamental tool in the initial characterization of FVII defects on "factor VII deficiency (Semin Thromb Hemost 2009;35(4):400-406)".

  Girolami A, Scandellari R, Lombardi AM. Girolami A, et al. Semin Thromb Hemost. 2010 Feb;36(1):123-4; author reply 125-7. doi: 10.1055/s-0030-1248731. Epub 2010 Apr 13. Semin Thromb Hemost. 2010. PMID: 20391303 No abstract available.
• [Significant decrease in factor VII activity by tissue thromboplastin derived from rabbit brain in a patient with congenital factor VII deficiency (FVII Padua)].

  Sekiya A, Morishita E, Maruyama K, Asakura H, Nakao S, Ohtake S. Sekiya A, et al. Rinsho Ketsueki. 2012 Mar;53(3):357-60. Rinsho Ketsueki. 2012. PMID: 22499055 Japanese.
• Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency.

  Branchini A, Rizzotto L, Mariani G, Napolitano M, Lapecorella M, Giansily-Blaizot M, Mari R, Canella A, Pinotti M, Bernardi F. Branchini A, et al. Haematologica. 2012 May;97(5):705-9. doi: 10.3324/haematol.2011.049403. Epub 2011 Dec 16. Haematologica. 2012. PMID: 22180436 Free PMC article.
• Inherited factor VII deficiency: genetics and molecular pathology.

  Tuddenham EG, Pemberton S, Cooper DN. Tuddenham EG, et al. Thromb Haemost. 1995 Jul;74(1):313-21. Thromb Haemost. 1995. PMID: 8578478 Review. No abstract available.
• Genetic aspects and research development in haemostasis.

  Tuddenham EG, Ingerslev J, Sørensen LN, Christiansen K, Mariani G, Peyvandi F, Waddington SN, Buckley SM, Kochanek S, Chuah MK, Vandendriessche T, Berntorp E. Tuddenham EG, et al. Haemophilia. 2008 Jul;14 Suppl 3:113-8. doi: 10.1111/j.1365-2516.2008.01740.x. Haemophilia. 2008. PMID: 18510530 Review. No abstract available.